Generation of CD20-specific TCRs for TCR gene therapy of CD20(low) B-cell malignancies insusceptible to CD20-targeting antibodies

Author(s):
Jahn, L.; Steen, D.M. van der; Hagedoorn, R.S.; Hombrink, P.; Kester, M.G.D.; Schoonakker, M.P.; Ridder, D. de; Veelen, P.A. van (0000-0002-7898-9408); Falkenburg, J.H.F.; Heemskerk, M.H.M. (0000-0001-6320-9133)
Published
2016
Publication type
Article / Letter to editor
CD20TCR gene transfermonoclonal antibodiesimmunotherapyB-cell leukemia and lymphoma
Date issued
2016-11-22
Language
English
Is part of
Oncotarget (2016), Vol. 7, no. 47, p. 77021-77037
hdl
1887/112981
doi
10.18632/oncotarget.12778